Vaccine escape recombinants emerge after pneumococcal vaccination in the United States.

Vaccine escape recombinants emerge after pneumococcal vaccination in the United States.

Show other versions (2)

The heptavalent pneumococcal conjugate vaccine (PCV7) was introduced in the United States (US) in 2000 and has significantly reduced invasive pneumococcal disease; however, the incidence of nonvaccine serotype invasive disease, particularly due to serotype 19A, has increased. The serotype 19A increa...

Bibliografske podrobnosti
Main Authors:	Brueggemann, A, Pai, R, Crook, D, Beall, B
Format:	Journal article
Jezik:	English
Izdano:	2007

Podobne knjige/članki

Vaccine escape recombinants emerge after pneumococcal vaccination in the United States
od: Brueggemann, A, et al.
Izdano: (2007)

Vaccine escape recombinants emerge after pneumococcal vaccination in the United States
od: Brueggemann, AB, et al.
Izdano: (2007)

Pneumococcal genome sequencing tracks a vaccine escape variant formed through a multi-fragment recombination event.
od: Golubchik, T, et al.
Izdano: (2012)

Pneumococcal genome sequencing tracks a vaccine escape variant formed through a multi-fragment recombination event
od: Golubchik, T, et al.
Izdano: (2012)

Evidence for soft selective sweeps in the evolution of pneumococcal multidrug resistance and vaccine escape.
od: Croucher, N, et al.
Izdano: (2014)

Impact of pneumococcal conjugate vaccines on hospitalizations for pneumonia in the United States
od: Andrew D. Wiese, et al.
Izdano: (2019-04-01)

Molecular epidemiology of paediatric invasive pneumococcal disease in southern Spain after the introduction of heptavalent pneumococcal conjugate vaccine.
od: Obando, I, et al.
Izdano: (2007)

An assessment of the screening method to evaluate vaccine effectiveness: the case of 7-valent pneumococcal conjugate vaccine in the United States.
od: Adam L Cohen, et al.
Izdano: (2012-01-01)

Pneumococcal Vaccination in the United States: Current Recommendations and Strategies to Improve Vaccination Coverage
od: Cynthia G Whitney
Izdano: (1999-01-01)

Pneumococcal Serotypes before and after Introduction of Conjugate Vaccines, United States, 1999–2011
od: Sandra S. Richter, et al.
Izdano: (2013-07-01)

State of pneumococcal vaccine immunity
od: Mustafa Akkoyunlu
Izdano: (2024-12-01)

Pneumococcal Vaccines
od: D. E. Briles, et al.
Izdano: (2019-12-01)

Invasive pneumococcal disease: epidemiology in children and adults prior to implementation of the conjugate vaccine in the Oxfordshire region, England.
od: Foster, D, et al.
Izdano: (2008)

An evaluation of emerging vaccines for childhood pneumococcal pneumonia
od: Zhang Jian Shayne F, et al.
Izdano: (2011-04-01)

Knowledge, attitudes, and perceptions towards pneumococcal vaccines among adults in the United States
od: Salini Mohanty, et al.
Izdano: (2025-12-01)

Preferences and attitudes of healthcare providers towards pneumococcal vaccines for adults in the United States
od: Salini Mohanty, et al.
Izdano: (2024-12-01)

Emerging vaccine strategies against the incessant pneumococcal disease
od: Jeremy A. Duke, et al.
Izdano: (2023-08-01)

Missed opportunities for pneumococcal vaccinations in high-risk and older adults in the United States
od: Omotola Olasupo, et al.
Izdano: (2020-01-01)

Invasive pneumococcal disease in England and Wales: vaccination implications.
od: Sleeman, K, et al.
Izdano: (2001)

Pneumococcal Conjugate Vaccination Followed by Pneumococcal Polysaccharide Vaccination in Lung Transplant Candidates and Recipients
od: Thijs W. Hoffman, MD, et al.
Izdano: (2020-06-01)

No long-term evidence of hyporesponsiveness after use of pneumococcal conjugate vaccine in children previously immunized with pneumococcal polysaccharide vaccine
od: Licciardi, P, et al.
Izdano: (2016)

Generalized granuloma annulare after pneumococcal vaccination,
od: Miguel Fernando García-Gil, et al.
Izdano: (2021-03-01)

Pneumococcal vaccination in developing countries.
od: Levine, O, et al.
Izdano: (2006)

Understanding healthcare providers’ preferred attributes of pediatric pneumococcal conjugate vaccines in the United States
od: Salini Mohanty, et al.
Izdano: (2024-12-01)

Variation of pneumococcal Pilus-1 expression results in vaccine escape during Experimental Otitis Media [EOM].
od: Marisol Figueira, et al.
Izdano: (2014-01-01)

Recent Topics of Pneumococcal Vaccination: Indication of Pneumococcal Vaccine for Individuals at a Risk of Pneumococcal Disease in Adults
od: Nobuhiro Asai, et al.
Izdano: (2021-11-01)

Pneumococcal vaccines in China
od: Shanshan Wang, et al.
Izdano: (2025-12-01)

A dynamic model of pneumococcal infection in the United States: implications for prevention through vaccination.
od: Van Effelterre, T, et al.
Izdano: (2010)

Pneumococcal responses are similar in Papua New Guinean children aged 3-5 years vaccinated in infancy with pneumococcal polysaccharide vaccine with or without prior pneumococcal conjugate vaccine, or without pneumococcal vaccination.
od: Anita H J van den Biggelaar, et al.
Izdano: (2017-01-01)

Decrease in pneumococcal co-colonization following vaccination with the seven-valent pneumococcal conjugate vaccine.
od: Carina Valente, et al.
Izdano: (2012-01-01)

Vaccination of Icelandic children with the 10-valent pneumococcal vaccine leads to a significant herd effect among adults in Iceland
od: Quirk, S, et al.
Izdano: (2019)

Invasive Pneumococcal Disease after Routine Pneumococcal Conjugate Vaccination in Children, England and Wales
od: Shamez N. Ladhani, et al.
Izdano: (2013-01-01)

Conjugation Mechanism for Pneumococcal Glycoconjugate Vaccines: Classic and Emerging Methods
od: Victor Morais, et al.
Izdano: (2022-12-01)

PNEUMOCOCCAL INFECTION VACCINAL PREVENTION EFFICACY IN CHILDREN USING PNEUMOCOCCAL CONJUGATED 7-VALENT VACCINE
od: N. L. Chernaya, et al.
Izdano: (2013-01-01)

Pneumococcal Nasopharyngeal Carriage in Young Healthy Children After Pneumococcal Conjugate Vaccine in Turkey
od: Ahmet Arvas, et al.
Izdano: (2017-08-01)

Population genetic structure of Streptococcus pneumoniae in Kilifi, Kenya, prior to the introduction of pneumococcal conjugate vaccine
od: Brueggemann, A, et al.
Izdano: (2013)

Population genetic structure of Streptococcus pneumoniae in Kilifi, Kenya, prior to the introduction of pneumococcal conjugate vaccine
od: Brueggemann, AB, et al.
Izdano: (2013)

VACCINE PREVENTION OF PNEUMOCOCCAL INFECTIONS IN ADULTS
od: A. A. Zaitsev, et al.
Izdano: (2017-11-01)

Disparities in uptake of 13-valent pneumococcal conjugate vaccine among older adults in the United States
od: John M. McLaughlin, et al.
Izdano: (2019-04-01)

23-Valent Pneumococcal Polysaccharide Vaccine Uptake in the United States Air Force HIV Program
od: Thad F. Ocampo MD, et al.
Izdano: (2016-07-01)